NCT04916002 2025-12-05
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
Regeneron Pharmaceuticals
Phase 2 Terminated
Regeneron Pharmaceuticals
Sol-Gel Technologies, Ltd.
Istituto Clinico Humanitas
University of Arizona
Stanford University
Hoffmann-La Roche
Novartis